Program - Thursday - November 5

10:00 a.m.-6:30 p.m.

Educational Session 1: Immunotherapy 101
Session Co-Chairpersons: Jolanda de Vries, Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands, and Mary L. (Nora) Disis, University of Washington, Seattle, Washington, USA
3:00 p.m.-4:30 p.m.

Immunity against cancer: How to be enhanced?
Jolanda de Vries

Gene-modified T cells as biotherapeutics for cancer
Stephen Gottschalk, Baylor College of Medicine, Houston, Texas, USA

Immune checkpoint inhibitors: Opportunities and challenges
Mary L. (Nora) Disis

Educational Session 2: Mutation Profiling / Return of Genetic Data

Session Co-Chairpersons: Lee J. Helman, National Cancer Institute, Bethesda, Maryland, USA, and Sharon E. Plon, Baylor College of Medicine, Houston, Texas, USA
4:45 p.m.-6:15 p.m.

Lee J. Helman

National scale cancer sequencing and treatment response data integration in The Netherlands
Edwin Cuppen, University Medical Center Utrecht, Utrecht, The Netherlands

Assigning clinical meaning to genomic data for cancer precision medicine
Nikhil Wagle, Dana-Farber Cancer Institute, Boston, Massachusetts, USA

Delivering of the promise of personalized medicine
Gordon B. Mills, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Disclosing Germline Results in Cancer Studies?
Sharon E. Plon

Closing remarks
Sharon E. Plon

Opening Networking Reception
6:30 p.m.-8:00 p.m.


Top of page